Treatment of Classic Pantothenate Kinase–Associated Neurodegeneration with Deferiprone and Intrathecal Baclofen
نویسندگان
چکیده
منابع مشابه
Intrathecal baclofen for the treatment of tetanus.
Tetanus remains a serious problem in public health, particularly in developing countries, despite efficient prevention programs. A retrospective study was conducted at an infectious diseases intensive care unit during 1998-2003 involving patients admitted with grade III tetanus. The aim of the study was to evaluate the efficacy and safety of intrathecal baclofen for the treatment of tetanus. Lu...
متن کاملA pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
Pantothenate kinase-associated neurodegeneration (PKAN) is the most common form of neurodegeneration with brain iron accumulation, it is an autosomal recessive disease due to mutation in PANK 2 on chromosome 20, which causes the accumulation of iron in basal ganglia and production of free radicals that cause degeneration of the cells. Deferiprone is an iron chelator that was used in treatment o...
متن کاملPantothenate kinase-associated neurodegeneration
9-years-old girl, previously healthy, presented with progressive dystonia. Clinically, she have dysarthria and spastic gait. Her parents are first-degree cousins. She have a paternal cousins who have a similar symptoms started 3 years ago, currently he is bed ridden. Notice: Authors are encouraged to submit quizzes for possible publication in the Journal. These may be in any field of Clinical N...
متن کاملStiff Person Syndrome with Good Treatment Response to Intrathecal Baclofen
Stiff person syndrome is a rare disorder affecting the musculoskeletal system due to an underlying autoimmune process. Our case describes a 36 year old female who presented with painful, distressing, intermittent muscular rigidity and a possible associated seizure disorder. The key highlight of our case is the misdiagnosis of her disease in the early stage and the successful management of stiff...
متن کاملChanges in body composition after spasticity treatment with intrathecal baclofen.
OBJECTIVE To assess changes in body composition, body weight and resting metabolic rate in patients who received intrathecal baclofen therapy for spasticity. DESIGN Prospective, longitudinal, quasi-experimental, with a pre/post design. PATIENTS Twelve patients with spasticity, fulfilling study criteria, and due for pump implantation for intrathecal baclofen therapy, completed the study. M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Physical Medicine & Rehabilitation
سال: 2013
ISSN: 0894-9115
DOI: 10.1097/phm.0b013e318282d209